June 03, 2025 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and ...

Cold chain monitoring solutions have become indispensable to the biopharma business for managing complicated supply chains.

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer application for approval.

There's no reason the U.S. can't pick up the pace to match the global clinical research front-runners without compromising ...

McKesson Corp. has announced plans to separate its Medical-Surgical Solutions segment into an independent company. This strategic move is aimed at sharpening McKesson’s focus on higher-growth, higher- ...

OXB (LSE: OXB) ("the Company”), a global quality and innovation-led cell and gene therapy CDMO, today highlights the launch ...

Related Disease - Market Insight, Epidemiology, and Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth understanding of historical and ...

The American Society for Clinical Oncology’s Annual Meeting for 2025 is, if nothing else, absolutely overwhelming and ...

The presentation details are as follows: Abstract Title: Reduction in Annualized Exacerbations with Rademikibart in Eosinophilic Driven, Type 2 Asthma Abstract Number: 001671 Presenter: Rekha ...

Cambridge UK and Tokyo biopharma business Nxera has hauled in $15 million after partner Neurocrine Biosciences dosed the ...

Agenus struck a $141 million agreement with Zydus Lifesciences that it said will accelerate clinical development, scale global manufacturing and expand patient access to its in-development cancer ...